Status:
COMPLETED
Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Chong Kun Dang Pharmaceutical
Conditions:
Nephrotic Syndrome
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE4
Brief Summary
To determine the efficacy of tacrolimus in the management of NS(nephrotic syndrome) , the investigators designed this prospective study. The investigators will enroll 100 children with NS(frequent rel...
Detailed Description
Subsequently , monthly measurements were made until stable levels of tacrolimus were achieved. Urine was analyzed for proteinuria at each visit. Serum creatinine, glucose, albumin and alanine aminotra...
Eligibility Criteria
Inclusion
- Frequent relapse nephrotic syndrome
- steroid resistance nephrotic syndrome
Exclusion
- secondary nephrotic syndrome
- estimated glomerular filtration rate \< 60 mL/min/1.73m2
- with active hepatitis
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT01162005
Start Date
July 1 2010
End Date
October 1 2013
Last Update
February 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744